These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26728634)

  • 1. Update on cardiotoxicity of anti-cancer treatments.
    Rosa GM; Gigli L; Tagliasacchi MI; Di Iorio C; Carbone F; Nencioni A; Montecucco F; Brunelli C
    Eur J Clin Invest; 2016 Mar; 46(3):264-84. PubMed ID: 26728634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.
    Galderisi M; Marra F; Esposito R; Lomoriello VS; Pardo M; de Divitiis O
    Cardiovasc Ultrasound; 2007 Jan; 5():4. PubMed ID: 17254324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
    Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
    Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and Management of Cardiotoxicity in Hematologic Malignancies.
    Bojan A; Torok-Vistai T; Parvu A
    Dis Markers; 2021; 2021():6616265. PubMed ID: 33613788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
    Saganelidze K; Kavtaradze N
    Georgian Med News; 2018 May; (278):87-93. PubMed ID: 29905551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity.
    Bordun KA; Premecz S; daSilva M; Mandal S; Goyal V; Glavinovic T; Cheung M; Cheung D; White CW; Chaudhary R; Freed DH; Villarraga HR; Herrmann J; Kohli M; Ravandi A; Thliveris J; Pitz M; Singal PK; Mulvagh S; Jassal DS
    Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H692-701. PubMed ID: 26092985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity of systemic agents used in breast cancer.
    Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
    Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab.
    Gulati G; Zhang KW; Scherrer-Crosbie M; Ky B
    Curr Heart Fail Rep; 2014 Dec; 11(4):366-73. PubMed ID: 25079445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
    Riccio G; Coppola C; Piscopo G; Capasso I; Maurea C; Esposito E; De Lorenzo C; Maurea N
    Hum Vaccin Immunother; 2016 May; 12(5):1124-31. PubMed ID: 26836985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current views on anthracycline cardiotoxicity.
    Mele D; Nardozza M; Spallarossa P; Frassoldati A; Tocchetti CG; Cadeddu C; Madonna R; Malagù M; Ferrari R; Mercuro G
    Heart Fail Rev; 2016 Sep; 21(5):621-34. PubMed ID: 27230651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of cardiovascular complications secondary to medical treatment of cancer].
    Banke A; Polk A; Nielsen D; Videbæk L; Overgaard U; Fosbøl EL; Vaage-Nielsen M; Nielsen KM; Schou M
    Ugeskr Laeger; 2018 Feb; 180(7):. PubMed ID: 29465031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.
    Stevens PL; Lenihan DJ
    Curr Cardiol Rep; 2015 Jul; 17(7):603. PubMed ID: 26026994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
    Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
    Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
    Rochette L; Guenancia C; Gudjoncik A; Hachet O; Zeller M; Cottin Y; Vergely C
    Trends Pharmacol Sci; 2015 Jun; 36(6):326-48. PubMed ID: 25895646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical predictors of anthracyclin and trastuzumab induced cardiotoxicity in early diagnostics of cardiomyopathy].
    Słowik A; Lelakowska-Pieła M; Konduracka E
    Pol Merkur Lekarski; 2016 Jan; 40(235):40-5. PubMed ID: 26891436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
    Garg V; Vorobiof G
    Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection of cancer therapeutics-related cardiac dysfunction].
    Potier A; Ederhy S; Ancedy Y; Etienney A; Soulat-Dufour L; Chauvet M; Hollebecque A; Adavane-Scheuble S; Boccara F; Soria JC; Cohen A
    Bull Cancer; 2016; 103(7-8):667-73. PubMed ID: 27417336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
    Merino T; Pinto MP; Orellana MP; Martinez G; Andía M; Munoz-Schuffenegger P; Acevedo F; Gabrielli L; Sanchez C; Pereira J
    BMC Cancer; 2021 Oct; 21(1):1114. PubMed ID: 34663256
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.